Velphoro Tablet, Chewable
Product Images NDC 49230-645

3 FDA label images from Fresenius Medical Care Renal Therapies Group, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Velphoro (NDC 49230-645). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Medical Care Renal Therapies Group, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Vel01 0000 01)

Figure 1 (Vel01 0000 01)
A line graph comparing change from baseline in serum phosphorus levels (mg/dL) over 52 weeks in patients treated with Velphoro (sucroferric oxyhydroxide) and sevelamer carbonate. The x-axis represents weeks on study treatment, with separate Study-05A and Study-05B phases marked. The y-axis shows change from baseline serum phosphorus. An inset graph shows change from baseline serum phosphorus from weeks 24 to 27 for Velphoro maintenance and low dose groups.*
FDA Label Image

Principal Display Label (Bottle Label)

Principal Display Label (Bottle Label)
Velphoro 500 mg chewable tablets label with active ingredient sucroferric oxyhydroxide. The label indicates that the product contains 90 chewable tablets and provides storage instructions and distributor information: Fresenius Medical Care North America, Waltham, MA. It also includes the NDC number 49230-645-51 and states the tablets should be chewed or crushed.*
FDA Label Image

Principal Display Label (Bottle Carton)

Principal Display Label (Bottle Carton)
Velphoro 500 mg chewable tablets packaging label showing the proprietary name Velphoro with the active ingredient sucroferric oxyhydroxide. The label indicates the oral dosage form as chewable tablets with a package count of 90 tablets. It includes storage instructions, inactive ingredients, and manufacturer information for Fresenius Medical Care Renal Therapies Group, LLC. The label also displays the NDC 49230-645-51 and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.